DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Emsam (Selegiline Transdermal) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Emsam (Selegiline Transdermal) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Emsam side effects in 46 year old female

Reported by a physician from United States on 2012-03-29

Patient: 46 year old female, weighing 54.4 kg (119.7 pounds)

Reactions: Tenosynovitis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Emsam
    Dosage: changed qd.
    Indication: Depression
    Start date: 2007-10-01
    End date: 2008-04-01

Emsam
    Dosage: changed qd.
    Start date: 2008-06-01
    End date: 2010-06-01

Emsam
    Dosage: changed qd.
    Start date: 2011-03-01
    End date: 2011-06-01

Other drugs received by patient: Sonata; Trazodone HCL; Acyclovir



Possible Emsam side effects in 49 year old male

Reported by a consumer/non-health professional from United States on 2012-01-04

Patient: 49 year old male, weighing 117.9 kg (259.4 pounds)

Reactions: Overdose, Incorrect Dose Administered, Product Adhesion Issue

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Emsam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017